Book contents
- Quality and Safety in Women’s Health
- Quality and Safety in Women’s Health
- Copyright page
- Contents
- Notes on Figures and Tables
- Contributors
- Preface
- Chapter 1 Office Safety
- Chapter 2 Electronic Fetal Monitoring and Patient Safety
- Chapter 3 Patient Safety in the Outpatient Setting
- Chapter 4 Principles for the Safe Use of Electrosurgery
- Chapter 5 The Obstetric-Gynecologic Hospitalist
- Chapter 6 Transparency and Disclosure
- Chapter 7 Surgical Checklists
- Chapter 8 What is a High-reliability Organization?
- Chapter 9 Powerful Tools for Quality Improvement
- Chapter 10 Simulation and Drills
- Chapter 11 Rapid Response in Obstetrics
- Chapter 12 Regulatory and Legal Implications
- Chapter 13 Patient Safety
- Chapter 14 Safety Programs in a Community Hospital
- Chapter 15 Improving Perinatal Safety in an Integrated Healthcare System
- Chapter 16 Fatigue and Safety
- Chapter 17 Just Culture in Women’s Health Services
- Chapter 18 Medication Safety in Obstetrics and Gynecology
- Chapter 19 Improving Patient Safety Through Team Training
- Chapter 20 A Systems-based Approach to Shoulder Dystocia Safety
- Chapter 21 Creating a Learning Culture
- Chapter 22 Safe Patient Handoffs
- Chapter 23 Using Clinical Scenarios to Teach Patient Safety
- Chapter 24 Quality and Safety in Medical Education
- Index
- References
Chapter 18 - Medication Safety in Obstetrics and Gynecology
Published online by Cambridge University Press: 15 March 2018
Edited by
Book contents
- Quality and Safety in Women’s Health
- Quality and Safety in Women’s Health
- Copyright page
- Contents
- Notes on Figures and Tables
- Contributors
- Preface
- Chapter 1 Office Safety
- Chapter 2 Electronic Fetal Monitoring and Patient Safety
- Chapter 3 Patient Safety in the Outpatient Setting
- Chapter 4 Principles for the Safe Use of Electrosurgery
- Chapter 5 The Obstetric-Gynecologic Hospitalist
- Chapter 6 Transparency and Disclosure
- Chapter 7 Surgical Checklists
- Chapter 8 What is a High-reliability Organization?
- Chapter 9 Powerful Tools for Quality Improvement
- Chapter 10 Simulation and Drills
- Chapter 11 Rapid Response in Obstetrics
- Chapter 12 Regulatory and Legal Implications
- Chapter 13 Patient Safety
- Chapter 14 Safety Programs in a Community Hospital
- Chapter 15 Improving Perinatal Safety in an Integrated Healthcare System
- Chapter 16 Fatigue and Safety
- Chapter 17 Just Culture in Women’s Health Services
- Chapter 18 Medication Safety in Obstetrics and Gynecology
- Chapter 19 Improving Patient Safety Through Team Training
- Chapter 20 A Systems-based Approach to Shoulder Dystocia Safety
- Chapter 21 Creating a Learning Culture
- Chapter 22 Safe Patient Handoffs
- Chapter 23 Using Clinical Scenarios to Teach Patient Safety
- Chapter 24 Quality and Safety in Medical Education
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Quality and Safety in Women's Health , pp. 157 - 168Publisher: Cambridge University PressPrint publication year: 2018
References
Simpson, KR, Knox, GE. Obstetrical accidents involving IV magnesium sulfate. Am J Maternal Child Nurs. 2004;29:161–171.CrossRefGoogle Scholar
Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy of Press; 2000.Google Scholar
ACOG Committee Opinion No. 447. Patient safety in obstetrics and gynecology. Obstet Gynecol. 2009;114:1424–1427.CrossRefGoogle Scholar
Cohen, M. Medication Errors, 2nd ed. Washington, DC: American Pharmacist Association; 2007.Google Scholar
Institute for Safe Medication Practices. ISMP’s list of high-alert medications. www.ismp.org/Tools/highalertmedications.pdf, updated 2012 (accessed April 1, 2013).Google Scholar
Kfuri, TA, Morlock, L, Hicks, RW, et al. Medication errors in obstetrics. Clin Perinatol. 2008;35:101–117.Google Scholar
Pa Patient Saf Advis 2009 Dec 16, 6[Suppl 1]:1–6.Google Scholar
Institute for Safe medication Practices. Proceedings from the ISMP Sterile Preparation Compounding Safety Summit: Guidelines for SAFE Preparation of Sterile compounds. www.ismp.org/Tools/guidelines/IVSummit/IVCGuidelines.pdf, updated 2013 (accessed April 1, 2013).Google Scholar
Cullen, DJ, Sweitzer, BJ, Bates, DW, Burdick, E, Edmondson, A, Leape, LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25:1289–1297.CrossRefGoogle ScholarPubMed
Parshuram, C, Ng, G, Ho, T, et al. Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med. 2003;31:2483–2487.Google Scholar
Joint Commission Medication Management Standards E-dition Version 5.0 Build 0.3, 2013. https://e-dition.jcrinc.com/MainContent.aspx (accessed April 1, 2013).Google Scholar
The Joint Commission. Official “Do not use” list. www.jointcommission.org/assets/1/18/Do_Not_Use_List.pdf, updated June 2012 (accessed April 1, 2013).Google Scholar
Institute for Safe Medication Practices. ISMP’s List of Error-Prone Abbreviations, Symbols, and Dose Designations. http://ismp.org/Tools/errorproneabbreviations.pdf, updated 2013 (accessed April 1, 2013).Google Scholar
Fidler, SA, Barger, DM. Patient Safety: Medication Safety in Obstetrics. ASHRM FORUM Q3 2011.Google Scholar
Ciarkowski, S, Stalburg, C. Medication safety in obstetrics and gynecology. Clin Obstet Gynecol. 2010; 53(3):482–499.CrossRefGoogle ScholarPubMed
Institute of Safe Medication Practices. FDA and ISMP Lists of Look-Alike Drug Names with Recommended Tall Man Letters. http://ismp.org/Tools/tallmanletters.pdf, updated 2011 (accessed April 13, 2013).Google Scholar
American College of Obstetricians and Gynecologists. Patient Safety in Obstetrics and Gynecology. ACOG Committee Opinion No. 447. Obstet Gynecol. 2009;114:1424–1427.CrossRefGoogle Scholar
American Society of Health-System Pharmacists. ASHP guidelines on the safe use of automated dispensing devices. Am J Health-Syst Pharm. 2010;67:483–490.Google Scholar
Rothschild, JM, Keohane, CA, Cook, EF, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33:533–540.CrossRefGoogle ScholarPubMed
Poon, EG, Keohane, CA, Yoon, CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010;362:1698–1707.Google Scholar
Lindenauer, PK, Remus, D, Roman, S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356:486–496.CrossRefGoogle ScholarPubMed
Institute for Safe Medication Practices. ISMP’s Quarterly Action Agenda. http://ismp.org/Newsletters/acutecare/actionagendas.asp, updated 2013 (accessed April 14, 2013).Google Scholar
Food and Drug Administration. FDA Pregnancy Categories. http://depts.washington.edu/druginfo/Formulary/Pregnancy.pdf (accessed April 10, 2013).Google Scholar
Briggs, GG, Freeman, RK, Yaffe, SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 9th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.Google Scholar
Oscarsson, ME, Amer-Wahlin, I, Rydhstroem, H, Kallen, K. Outcome in obstetric care related to oxytocin use. A population-based study. Acta Obstet Gynecol Scand. 2006;85:1094–1098.Google Scholar
Lexi-comp’s Drug Information Handbook, 21st ed. Hudson, OH: American Pharmacists Association; 2012: 1272–1273.Google Scholar
Amico, JA, Seitchik, J, Robinson, AG. Studies of oxytocin in plasma of women during hypocontractile labor. J Clin Endocrinol Metab. 1984;58:274–279.Google Scholar
Seitchik, J, Amico, J, Robinson, AG, Castillo, M. Oxytocin augmentation of dysfunctional labor. IV. Oxytocin pharmacokinetics. Am J Obstet Gynecol. 1984;150:225–228.Google Scholar
Simpson, K, James, D. Effects of oxytocin induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns. Obstet Gynecol. 2008;199:34.e1–34.e5.Google Scholar
Lexi-comp’s Drug Information Handbook, 21st edition. Hudson, OH: American Pharmacists Association; 2012: 1047–1049.Google Scholar
Up-to-Date. Adverse events of prostaglandins. www.uptodate.com.libproxy.lib.unc.edu/contents/search-comp (accessed April 2, 2013).Google Scholar
Chong, Y, Chua, S, Shen, L, et al. Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery. Eur J Obstet Gynecol Reprod Biol. 2004;113:191–198.CrossRefGoogle ScholarPubMed
Lexi-comp’s Drug Information Handbook, 21st edition. Hudson, OH: American Pharmacists Association; 2012: 1141–1142.Google Scholar
Lexi-comp’s Drug Information Handbook, 21st edition. Hudson, OH: American Pharmacists Association; 2012: 1098–1102.Google Scholar
ACOG Committee Opinion No. 485. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2011;117(4):1019–1027. www.acog.org/~/media/Committee%20Opinions/Committee%20on%20Obstetric%20Practice/co485.pdf?dmc=1&ts=20130415T1508315558 (accessed April 4, 2013).Google Scholar
Verani, JR, McGee, L, Schrag, SJ. Prevention of perinatal group B streptococcal disease – revised guidelines from CDC, 2010. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep. 2010;59(RR–10):1–36.Google Scholar